144 filed Oct 14, 2026 at 16:01 ET
Director Alex M. Azar II filed a Form 144 notice of intent to sell 69 shares of Guardant Health common stock, with an estimated aggregate market value of approximately $11,032. The shares were acquired via a restricted stock lapse on October 12, 2026, and the sale is for equity compensation-related tax purposes. The proposed sale is de minimis in size relative to the company's market cap and the insider's likely holdings, carrying minimal signaling value.